Journal
NATURE REVIEWS CANCER
Volume 5, Issue 12, Pages 921-929Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1753
Keywords
-
Categories
Ask authors/readers for more resources
There have long been indications of a role for PI3K (phosphatidylinositol 3-kinase) in cancer pathogenesis. Experimental data document a requirement for deregulation of both transcription and translation in PI3K-mediated oncogenic transformation. The recent discoveries of cancer-specific mutations in PIK3CA, the gene that encodes the catalytic subunit p110 alpha of PI3K, have heightened the interest in the oncogenic potential of this lipid kinase and have made p110 alpha an ideal drug target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available